- Home
- ALGS vs GEG Comparison
ALGS vs GEG Comparison
Compare ALGS & GEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- GEG
- Stock Information
- Founded
- ALGS 2018
- GEG 1994
- Country
- ALGS United States
- GEG United States
- Employees
- ALGS N/A
- GEG N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- GEG Computer Software: Prepackaged Software
- Sector
- ALGS Health Care
- GEG Technology
- Exchange
- ALGS Nasdaq
- GEG Nasdaq
- Market Cap
- ALGS 50.4M
- GEG 60.4M
- IPO Year
- ALGS 2020
- GEG N/A
- Fundamental
- Price
- ALGS $7.84
- GEG $2.07
- Analyst Decision
- ALGS Strong Buy
- GEG
- Analyst Count
- ALGS 1
- GEG 0
- Target Price
- ALGS $70.00
- GEG N/A
- AVG Volume (30 Days)
- ALGS 125.8K
- GEG 9.8K
- Earning Date
- ALGS 08-05-2025
- GEG 08-28-2025
- Dividend Yield
- ALGS N/A
- GEG N/A
- EPS Growth
- ALGS N/A
- GEG N/A
- EPS
- ALGS N/A
- GEG N/A
- Revenue
- ALGS $3,270,000.00
- GEG $19,626,000.00
- Revenue This Year
- ALGS N/A
- GEG N/A
- Revenue Next Year
- ALGS $51.55
- GEG N/A
- P/E Ratio
- ALGS N/A
- GEG N/A
- Revenue Growth
- ALGS N/A
- GEG 64.34
- 52 Week Low
- ALGS $3.76
- GEG $1.70
- 52 Week High
- ALGS $46.80
- GEG $2.33
- Technical
- Relative Strength Index (RSI)
- ALGS 57.02
- GEG 44.46
- Support Level
- ALGS $6.82
- GEG $1.96
- Resistance Level
- ALGS $8.66
- GEG $2.15
- Average True Range (ATR)
- ALGS 0.76
- GEG 0.09
- MACD
- ALGS -0.06
- GEG -0.02
- Stochastic Oscillator
- ALGS 55.49
- GEG 29.73
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.